2-氯脱氧腺苷治疗多发性骨髓瘤 - Suppr

Suppr

超能文献

2-Chlorodeoxyadenosine in the treatment of multiple myeloma.

作者信息

Dimopoulos M A, Kantarjian H M, Estey E H, Alexanian R

出版信息

Blood. 1992 Sep 15;80(6):1626.

PMID:1355673

Abstract

摘要

相似文献

2-Chlorodeoxyadenosine in the treatment of multiple myeloma.2-氯脱氧腺苷治疗多发性骨髓瘤

Blood. 1992 Sep 15;80(6):1626.

2-Chlorodeoxyadenosine treatment of lymphoid malignancies.2-氯脱氧腺苷治疗淋巴系统恶性肿瘤

Blood. 1992 Feb 15;79(4):843-5.

Clinical trials referral resource. Clinical trials with 2-chlorodeoxyadenosine.临床试验转诊资源。关于2-氯脱氧腺苷的临床试验。

Oncology (Williston Park). 1992 May;6(5):95-8.

Pentostatin and 2-chlorodeoxyadenosine for hairy-cell leukemia.喷司他丁和2-氯脱氧腺苷治疗毛细胞白血病。

Med Lett Drugs Ther. 1992 Sep 18;34(879):89-90.

The purine analogs--a therapeutic beauty contest.嘌呤类似物——一场治疗领域的“选美大赛”

J Clin Oncol. 1992 May;10(5):868-71. doi: 10.1200/JCO.1992.10.5.868.

The purine analogs--a therapeutic beauty contest.嘌呤类似物——一场治疗领域的“选美大赛”

J Clin Oncol. 1992 Mar;10(3):352-5. doi: 10.1200/JCO.1992.10.3.352.

New purine analogues for the treatment of chronic B-cell malignancies.用于治疗慢性B细胞恶性肿瘤的新型嘌呤类似物。

Henry Ford Hosp Med J. 1991;39(2):98-102.

Response to 2-chlorodeoxyadenosine in patients with B-cell chronic lymphocytic leukemia resistant to fludarabine.对氟达拉滨耐药的B细胞慢性淋巴细胞白血病患者对2-氯脱氧腺苷的反应。

N Engl J Med. 1992 Oct 8;327(15):1056-61. doi: 10.1056/NEJM199210083271504.

Lasting remissions in hairy-cell leukemia induced by a single infusion of 2-chlorodeoxyadenosine.单次输注2-氯脱氧腺苷诱导毛细胞白血病持久缓解。

N Engl J Med. 1990 Apr 19;322(16):1117-21. doi: 10.1056/NEJM199004193221605.

Splenic lymphoma with villous lymphocytes (SLVL) responding to 2-chlorodeoxyadenosine (2-CdA).脾绒毛状淋巴细胞淋巴瘤（SLVL）对2-氯脱氧腺苷（2-CdA）有反应。

Br J Haematol. 1998 Mar;100(3):609. doi: 10.1046/j.1365-2141.1998.0636f.x.

引用本文的文献

Cladribine and bendamustine exhibit inhibitory activity in dexamethasone-sensitive and -resistant multiple myeloma cells.克拉屈滨和苯达莫司汀对地塞米松敏感和耐药的多发性骨髓瘤细胞均有抑制活性。

Am J Transl Res. 2013;5(1):36-46. Epub 2013 Jan 21.

Drug response in a genetically engineered mouse model of multiple myeloma is predictive of clinical efficacy.在多发性骨髓瘤的基因工程小鼠模型中，药物反应可预测临床疗效。

Blood. 2012 Jul 12;120(2):376-85. doi: 10.1182/blood-2012-02-412783. Epub 2012 Mar 26.

Therapeutic potential of cladribine in combination with STAT3 inhibitor against multiple myeloma.克拉屈滨联合 STAT3 抑制剂治疗多发性骨髓瘤的治疗潜力。

BMC Cancer. 2011 Jun 16;11:255. doi: 10.1186/1471-2407-11-255.

The effects of forodesine in murine and human multiple myeloma cells.福罗地辛对小鼠和人类多发性骨髓瘤细胞的作用。

Adv Hematol. 2010;2010:131895. doi: 10.1155/2010/131895. Epub 2010 Oct 19.

Clinical and toxicological aspects of the antineoplastic drug cladribine: a review.抗肿瘤药物克拉屈滨的临床与毒理学研究进展：综述

Ann Hematol. 1994 Nov;69(5):223-30. doi: 10.1007/BF01700276.

Cladribine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in haematological malignancies.克拉屈滨。对其血液系统恶性肿瘤的药效学、药代动力学特性及治疗潜力的综述。

Drugs. 1993 Nov;46(5):872-94. doi: 10.2165/00003495-199346050-00007.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验